Suzuki Y, Katayama Y, Fujimoto Y, Kobori I, Tamano M. Non-improvement of atrophic gastritis in cases of gastric cancer after successful Helicobacter pylori eradication therapy. World J Clin Cases 2024; 12(14): 2342-2349 [PMID: 38765755 DOI: 10.12998/wjcc.v12.i14.2342]
Corresponding Author of This Article
Yasumi Katayama, MD, PhD, Academic Research, Professor, Department of Gastroenterology, Dokkyo medical University Saitama Medical Center, Minami-Koshigaya 2-1-50, Saitama 343-8555, Japan. yasumi@dokkyomed.ac.jp
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. May 16, 2024; 12(14): 2342-2349 Published online May 16, 2024. doi: 10.12998/wjcc.v12.i14.2342
Table 1 Grading system for the Kyoto classification score
Parameter
Score
Atrophy
0
C0–CI according to Kimura-Takemoto classification
1
CII–CIII
2
OI–OIII
Intestinal metaplasia
0
None
1
Within the antrum
2
Up to corpus
Hypertrophy of gastrid folds
0
None
1
Positive
Nodularity
0
None
1
Positive
Diffuse redness
0
None
1
Mild (with RAC)
2
Severe
Table 2 Modified atrophy score
Modified atrophy score
Kimura-Takemoto classification
0
C0
1
CI
2
CII
3
CIII
4
OI
5
OII
6
OIII
Table 3 Patients’ characteristics
Characteristics
Gastric cancer
Gastritis
P value
Number
30
30
Age (yr ± SD)
75.3
73.9
0.695
Sex (M:F)
21:9
17:13
0.422
Differentiation (tub1-2: Sig-por)
29:1
Depth (m: Sm)
30:0
Table 4 Each parameter of the Kyoto classification at the time of onset of gastric cancer and three years before onset of gastric cancer
Parameters
1st EGD
2nd EGD
P value
1st EGD
2nd EGD
P value
1st EGD
2nd EGD
P value
A
IM
H
GC
2
2
1
1.27 ± 0.74
1.27 ± 0.74
1
0.43 ± 0.09
0.50 ± 0.504
0.543
GA
1.9±0.305
1.9±0.305
1
0.8 ± 0.76
0.87 ± 0.78
0.326
0.37 ± 0.09
0.367 ± 0.490
0.184
P value
0.0415
0.0415
0.0192
0.046
0.605
0.281
N
DR
GC
0.03 ± 0.183
0.03 ± 0.183
1
1.27 ± 0.83
0.5 ± 0.82
0.0004
GA
0.03 ± 0.183
0
0.326
0.95 ± 0.17
0.07 ± 0.37
0.0008
P value
1
0.326
0.017
0.012
Citation: Suzuki Y, Katayama Y, Fujimoto Y, Kobori I, Tamano M. Non-improvement of atrophic gastritis in cases of gastric cancer after successful Helicobacter pylori eradication therapy. World J Clin Cases 2024; 12(14): 2342-2349